step 1 trial semaglutide 2.4 mg weight loss nejm 2021 Once-Weekly in Adults with Overweight or Obesity STEP 1 Trial — Semaglutide

[11] Muscle Preservation and Energy Expenditure DEXA: only 38% of weight loss from lean mass (stable absolute lean mass)

Supplement Facts: Serving Size: 5 mL (approx

Metered Spray Delivery Designed to dispense a consistent volume with each spray

These mechanisms contribute to improved glycaemic control, and clinical trials have demonstrated that Wegovy can reduce HbA1c levels in people with type 2 diabetes

In the U.S., the Centers for Disease Control and Prevention reports more than 100 million adults, or about 42 percent of the population, are living with obesity, accounting for $173 billion in medical expenditures